Latest news and insights on the pharmaceutical industry | Indian Pharma Post

Results For "Saudi-Arabia"

47 News Found

Venus Remedies secures global approval for Plerixafor in Saudi Arabia
Drug Approval | May 22, 2026

Venus Remedies secures global approval for Plerixafor in Saudi Arabia

SFDA nod marks company’s strategic entry into high-value specialty oncology injectables as it targets expanding stem cell transplant and haemato-oncology market in the GCC region


Co-Diagnostics JV leases manufacturing facility in Saudi Arabia
Medical Device | May 11, 2026

Co-Diagnostics JV leases manufacturing facility in Saudi Arabia

CoMira Diagnostics will manufacture PCR diagnostic instruments and medical consumables in Sudair Industrial City


Cupid to set up FMCG manufacturing facility in Saudi Arabia
News | December 30, 2025

Cupid to set up FMCG manufacturing facility in Saudi Arabia

The plant is expected to enhance regional supply capabilities


Cupid to acquire strategic stake in Mansam fragrance brand, Saudi Arabia
News | September 10, 2025

Cupid to acquire strategic stake in Mansam fragrance brand, Saudi Arabia

Mansam, founded in 2022, is positioned as the first Arabian luxury fragrance brand with a vision for global expansion


Venus Remedies gets marketing approvals from Philippines, Saudi Arabia for three drugs
News | December 07, 2023

Venus Remedies gets marketing approvals from Philippines, Saudi Arabia for three drugs

Venus Remedies is supplying the drug to many countries like Colombia, Thailand, Tanzania, Morocco, Myanmar, Indonesia, Saudi Arabia, Malaysia, Zimbabwe, Sri Lanka, Pakistan, Kenya, and Botswana


Venus Remedies granted market authorizations in Saudi Arabia and Philippines
News | December 02, 2023

Venus Remedies granted market authorizations in Saudi Arabia and Philippines

These regulatory approvals signify a significant milestone for Venus Remedies Limited


Cipla appoints Taher Karampurwala as Senior Director and Head of Middle East Business
People | June 03, 2026

Cipla appoints Taher Karampurwala as Senior Director and Head of Middle East Business

Veteran pharmaceutical executive to relocate to Saudi Arabia and spearhead Cipla’s growth strategy across the Middle East region


FDA delays AstraZeneca decision on camizestrant as regulators seek more data
Drug Approval | May 30, 2026

FDA delays AstraZeneca decision on camizestrant as regulators seek more data

The filing is backed by results from the pivotal SERENA-6 Phase III trial


Fabtech Technologies FY26 revenue rises 28% to Rs 431 crore
News | May 01, 2026

Fabtech Technologies FY26 revenue rises 28% to Rs 431 crore

Pharma and biotech infrastructure firm targets 25–30% growth as Middle East and Africa emerge as key expansion markets